Echo IQ Limited (EIQ)
CXA 
Summary
Echo IQ Limited (EIQ) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Echo IQ Limited ever had a stock split?
Echo IQ Limited Profile
| Software Industry | Information Technology Sector | Mr. Andrew Grover CEO | CXA Exchange | AU0000195430 ISIN |
| AU Country | - Employees | - Last Dividend | 13 Aug 2019 Last Split | - IPO Date |
Overview
Echo IQ Limited is an innovative company focused on the development of artificial intelligence-based diagnostic tools aimed at enhancing the detection and diagnosis of structural heart disease. This technology-centric organization has made significant strides in the healthcare sector within Australia and the United Kingdom by leveraging advanced AI methodologies to aid physicians and health systems in the accurate assessment of heart conditions. Initially known as Houston We Have Limited, the company underwent a rebranding process in December 2021, adopting the name EchoIQ Limited to better reflect its core mission and services. Headquartered in Sydney, Australia, Echo IQ Limited is committed to advancing the field of cardiology diagnostics through its cutting-edge solutions.
Products and Services
- EchoSolvTM
This proprietary software developed by Echo IQ Limited plays a critical role in the identification and diagnosis of Aortic Stenosis, a severe heart condition characterized by the narrowing of the aortic valve opening. EchoSolvTM applies innovative artificial intelligence algorithms to improve the accuracy and efficiency of diagnosing this condition, thereby supporting physicians in developing more effective treatment plans for patients.
